Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tejnaksh HealthcareBOM:539428 -1.72%72 Shareholder Yield % is 4.48% as of Mar. 2026, which is 283% above its 10-year median of 1.17. GuruFocus rates BOM:539428 with a GF Score™ of 72/100 and a GF Value™ of ₹20.94 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 652 Healthcare Providers & Services companies, Tejnaksh Healthcare ranks better than 75% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Tejnaksh Healthcare's Shareholder Yield % was 4.48%.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Tejnaksh Healthcare Shareholder Yield % Related Terms
Tejnaksh Healthcare Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Tejnaksh Healthcare's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539428 vs HCA, THC, DVA: Shareholder Yield % Comparison
For the Medical Care Facilities subindustry, Tejnaksh Healthcare's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tejnaksh Healthcare Shareholder Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tejnaksh Healthcare's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Tejnaksh Healthcare's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Tejnaksh Healthcare (BOM:539428) has a Shareholder Yield % of 4.48% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Tejnaksh Healthcare and its competitors. This is 283% above median its historical median of 1.17. According to the industry distribution chart, Tejnaksh Healthcare ranks #163 out of 652 companies in the Healthcare Providers & Services industry, placing it in the top 25%.
Is Tejnaksh Healthcare's Shareholder Yield % too high?
Tejnaksh Healthcare's current Shareholder Yield % of 4.48% is 283% above median its 10-year median of 1.17. The Healthcare Providers & Services industry median Shareholder Yield % is 0.05. Tejnaksh Healthcare's value of 4.48% is 8860% above this industry median. Based on the distribution chart, Tejnaksh Healthcare ranks #163 out of 652 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Tejnaksh Healthcare has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tejnaksh Healthcare's Shareholder Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tejnaksh Healthcare ranks #163 out of 652 companies for Shareholder Yield %. This places Tejnaksh Healthcare in the top 25% of its industry — outperforming the majority of peers. The industry median Shareholder Yield % is 0.05. Tejnaksh Healthcare's value of 4.48% is 8860% above this benchmark. While the company's 10-year median is 1.17 vs. the industry median of 0.05, Tejnaksh Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Healthcare Providers & Services company?
The median Shareholder Yield % among Healthcare Providers & Services companies is 0.05, based on 652 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tejnaksh Healthcare's current Shareholder Yield % of 4.48% is 8860% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Tejnaksh Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Shareholder Yield % is 0.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tejnaksh Healthcare's current Shareholder Yield % is 4.48%, which is 283% above median its own 10-year median of 1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tejnaksh Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Tejnaksh Healthcare (BOM:539428) is currently considered Possible Value Trap. The stock's GF Value™ is ₹20.94, compared to a current price of ₹13.72 — trading 34.5% below its estimated fair value. The current Shareholder Yield % is 4.48%, which is 283% above median its 10-year median of 1.17 and 8860% above the Healthcare Providers & Services industry median of 0.05. Tejnaksh Healthcare's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Tejnaksh Healthcare (BOM:539428), the current Shareholder Yield % is 4.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tejnaksh Healthcare (BOM:539428) Overvalued in 2026?
Based on GuruFocus' analysis, Tejnaksh Healthcare stock appears to be undervalued.
The current stock price of ₹13.72 is trading 34.5% below its estimated GF Value™ of ₹20.94.
GuruFocus considers Tejnaksh Healthcare to be Possible Value Trap.
Key valuation signals for BOM:539428:
Shareholder Yield %: 4.48% (283% above median its 10-year median of 1.17)
GF Value™: ₹20.94 vs. price of ₹13.72 (34.5% below fair value)
Industry Position: 8860% above the Healthcare Providers & Services median (#163 of 652)
No single metric tells the full story. See the BOM:539428 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tejnaksh Healthcare Ltd is engaged in the provision of hospital and healthcare services. Geographically, it operates only in India. The company has a single operating segment, namely health care services. The company domains include Urology Hospitals; Nephrology Hospitals; Dental Clinics; Healthcare Equipment, Research and Development and others. It generates maximum revenue from fees charged under contract for inpatient and outpatient hospital services and also includes sale of medical and non-medical items. Hospital services include charges for accommodation, medical professional services, pathology and pharmaceutical goods used in treatments given to patient.
72GF Score
Get the complete analysis for BOM:539428
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539428 has been successfully added to your 
